# FDA recall D-0105-2015

> **Martin Avenue Pharmacy, Inc.** · Class II · drug recall initiated 2014-08-27.

## Product

Morphine/bupivacaine 5 mg/2 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

## Reason for recall

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0105-2015
- **Recalling firm:** Martin Avenue Pharmacy, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-08-27
- **Report date:** 2014-11-05
- **Termination date:** 2018-05-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Naperville, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0105-2015

## Citation

> AI Analytics. FDA recall D-0105-2015. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0105-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*